Dasatinib is an oral inhibitor of Bcr-Abl tyrosine-kinase, Src family tyrosine kinases, c-Kit, and ephrin receptors. It is being evaluated for use in numerous cancers, including advanced prostate cancer.
Product Details
| Alternative Name: | BMS-354825, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide |
| |
| Formula: | C22H26ClN7O2S |
| |
| MW: | 488 |
| |
| CAS: | 302962-49-8 |
| |
| Purity: | ≥99% (HPLC) |
| |
| Identity: | Determined by EM-MS, NMR |
| |
| Appearance: | White powder. |
| |
| Solubility: | Soluble in DMSO (98mg/ml) or ethanol (1mg/ml). |
| |
| Shipping: | Ambient Temperature |
| |
| Short Term Storage: | +4°C |
| |
| Long Term Storage: | -20°C |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
